The term "non-specific" is widely used to describe proteins that bind DNA or RNA substrates at sites without apparent sequence or structure signatures ^[@R1],[@R2],[@R5]^. Although "non-specific" proteins are numerous and play many important biological roles, it is a central open question whether the absence of defined recognition elements in nucleic acid binding sites reflects largely indiscriminate substrate binding, or if and how non-specific proteins discriminate between different binding sites. To answer this question, we systematically examined substrate binding for the apparently non-specific RNA binding protein C5, the protein subunit of RNase P from *E. coli*. RNase P is a ribonucleoprotein enzyme that removes 5′ leader sequences from precursor tRNA (ptRNA) in Bacteria ^[@R7]^ ([Fig. 1a](#F1){ref-type="fig"}). The C5 protein promotes ptRNA processing by RNase P ^[@R8]^, and contributes to ptRNA binding by associating with six consecutive nucleotides in the 5′ ptRNA leaders ^[@R9],[@R10]^ ([Fig. 1a,b](#F1){ref-type="fig"}). This binding site displays no apparent sequence or structure signatures in the 87 genomically encoded *E. coli* ptRNA leaders ([Extended Data Fig. 1](#SD2){ref-type="supplementary-material"}).

To determine whether and how C5 discriminates between different binding sites, we measured functional binding of C5 to all sequence variants in its cognate ptRNA site. Here, functional binding reflects productive substrate association in an ongoing enzymatic reaction. It is expressed by the specificity constant (*k*~cat~/*K*~m~) for a given substrate variant, which measures biologically relevant specificity ^[@R11],[@R12]^. To simultaneously determine functional binding of C5 to all substrate variants, we generated precursor tRNA (non-initiator ptRNA^Met^) with a randomized C5 binding site ([Fig. 1c](#F1){ref-type="fig"}), and followed the processing reaction of this ptRNA^Met(-3-8N)^ population ([Fig. 1d](#F1){ref-type="fig"}). Reactions were conducted with excess ptRNA^Met(-3-8N)^. Under these multiple turnover conditions all sequence variants compete for C5 association, and the relative reaction rate for each variant reflects functional binding ^[@R13]^.

The timecourse for the reaction of the randomized ptRNA^Met(-3-8N)^ population differed markedly from the timecourse of ptRNA^Met82^ with a genomically encoded leader ([Fig. 1d](#F1){ref-type="fig"}). This difference indicates that sequence variation affects functional binding by C5. Removal of C5 slowed the reaction rate as expected and greatly diminished the kinetic differences between the substrates with the genomically encoded and the randomized leaders ([Fig. 1d](#F1){ref-type="fig"}).

To determine reaction rate constants for the individual substrate variants, we isolated remaining substrates at various reaction times and measured the distribution of the RNA species by *Illumina* sequencing ([Fig. 1e,f](#F1){ref-type="fig"}, [Extended Data Fig. 2](#SD3){ref-type="supplementary-material"}, [Extended Data Tab. 1](#SD4){ref-type="supplementary-material"}). We used primers with degenerate barcodes to detect biased amplification of sequences during the PCR ([Extended Data Fig. 2](#SD3){ref-type="supplementary-material"}, [Extended Data Tab. 1](#SD4){ref-type="supplementary-material"}). Of the 4,096 sequence variants, 2,900 showed unbiased amplification and were retained for further analysis. The distribution of sequence variants changed over the reaction time, revealing distinct fast and slow reacting species ([Fig. 1f](#F1){ref-type="fig"}). These data demonstrate that C5 discriminates between different sequence variants, despite the lack of sequence signatures in genomically encoded *E. coli* ptRNA leaders.

We calculated a relative processing rate constant ^r^*k* for each RNA variant, using internal competition analysis, developed for the evaluation of kinetic isotope effects ([Extended Data Fig. 3](#SD5){ref-type="supplementary-material"}) ^[@R13]--[@R15]^. The ^r^*k* value is the ratio between the k~cat~/K~m~ values for the given sequence variant and our reference sequence, the physiological leader AAAAAG. The relative rate constants for all sequence variants describe C5 binding to the entire sequence space of the six nucleotide recognition site. Our approach to measure functional binding of large numbers of substrates during an ongoing reaction adds a kinetic dimension to the scope of high throughput sequencing experiments with randomized RNA populations ^[@R3],[@R4],[@R16],[@R17]^. We therefore propose to term our method [Hi]{.ul}gh [T]{.ul}hroughput [S]{.ul}equencing [Kin]{.ul}etics (HiTS-Kin). The approach is applicable to other systems for kinetic analysis of next generation sequencing data.

For the ptRNA processing reaction with C5, the HiTS-Kin method revealed a range of relative rate constants spanning several orders of magnitude ([Fig. 2a](#F2){ref-type="fig"}). Obtained relative rate constants were highly reproducible in independent experiments ([Fig. 2b](#F2){ref-type="fig"}). We also validated rate constants by direct kinetic measurements of selected sequence variants ([Fig. 2c](#F2){ref-type="fig"}, [Extended Data Fig. 4](#SD6){ref-type="supplementary-material"}). Together, these data show that the HiTS-Kin approach provides reproducible and accurate relative rate constants.

Next, we plotted the number of sequence variants processed at a given range of relative rate constants ([Fig. 2d](#F2){ref-type="fig"}). The resulting histogram revealed that a significant number of sequence variants reacted faster than the physiological leader reference (^r^*k* \> 1). Numerous sequence variants reacted slower (^r^*k* \< 1). These observations indicate that physiological leader sequences of non-initiator ptRNA^Met^ are not preferentially bound by C5. Removal of C5 greatly contracted the range of relative rate constants, highlighting the impact of C5 on functional substrate binding and on the characteristic affinity distribution ([Extended Data Fig. 5](#SD7){ref-type="supplementary-material"}).

Most strikingly, the shape of the distribution of functional C5 affinities closely resembled affinity distributions of highly specific DNA binding proteins, for which large numbers of sequence variants had been examined ^[@R18]--[@R21]^ ([Fig. 2d](#F2){ref-type="fig"}). This degree of similarity between the non-specific C5 and specific proteins was unexpected, given the absence of sequence signatures in the C5 binding site. For specific proteins, the cellular substrates that define binding site signatures are found at the high affinity tail of the distribution ^[@R18],[@R19]^ ([Extended Data Fig. 6a,b](#SD8){ref-type="supplementary-material"}). Remarkably, this high affinity region for C5 also shows a clear sequence signature ([Fig. 2e,f](#F2){ref-type="fig"}), as seen for specific proteins. In stark contrast to specific proteins, the C5 sequence signature does not correspond to the physiological binding sites on the non-initiator ptRNA^Met^. None of the genomically encoded non-initiator ptRNA^Met^ leader sequences falls into this fastest reacting fraction ([Fig. 2d](#F2){ref-type="fig"}). For both C5 and specific proteins, no sequence signatures were detected for other regions of the sequence spectrum ([Extended Data Fig. 6](#SD8){ref-type="supplementary-material"}). Our results thus reveal remarkable similarities between sequence discrimination by the apparently non-specific C5 and by specific DNA binding proteins. At the same time, our data highlight a major difference: sequences bound with the highest affinity do not represent physiological substrates for C5, but for specific DNA binding proteins with known affinity distributions.

To delineate sequence determinants that govern substrate recognition by C5, we fit the distribution of rate constants to models of increasing complexity and determined which percentage of the measured variance in the rate constants was explained by the respective model. Our simplest model considered only the number of a given nucleotide in the binding site, regardless of position. This model explained 29% of the variance in the measured rate constants ([Fig. 3a](#F3){ref-type="fig"}, left panel). The model suggested favorable binding of A/U rich sequences ([Extended Data Fig. 7a](#SD9){ref-type="supplementary-material"}). Since A/U basepairs are thermodynamically less stable than G/C basepairs, we speculate that the variance explained by this model reflects in part the propensity of the leader to form transient structures with other parts of the ptRNA ^[@R22]^, which potentially compete with C5 binding. While competing structures are generally expected in RNAs with more than two dozen nucleotides ^[@R23]^, the relatively low correlation of the model with measured rate constants suggests that competing RNA structures have only limited impact on C5 binding for the majority of sequences.

We next considered both base identity and position in the binding site. This model, a traditional Position Weight Matrix ^[@R21]^, explained 39% of the variance in measured rate constants ([Fig. 3a](#F3){ref-type="fig"} middle panel, [Extended Data Fig. 7b](#SD9){ref-type="supplementary-material"}). This modest improvement over the previous model indicated that the position of individual bases in the binding site impacted C5 binding only to a limited extent. However, the Position Weight Matrix assesses the bases independent of each other ^[@R21]^. To probe interdependence of the bases in the binding site, we employed a model accounting for functional coupling between two bases. This model explained 68% of the variance in measured rate constants ([Fig. 3a](#F3){ref-type="fig"}, right panel). The strongest couplings were detected between neighboring bases ([Fig. 3b](#F3){ref-type="fig"}).

The observed strength of the couplings between adjacent bases did not scale with energies expected to overcome stacking of the respective bases ^[@R22]^. This finding suggests that the couplings result from interactions of the RNA with C5, not primarily from inherent RNA conformations. Functional couplings between more than two base positions, assessed by neural network analysis, only modestly improved correlation between predicted and measured data, and explained 76% of the variance ([Extended Data Fig. 8](#SD10){ref-type="supplementary-material"}). Thus, functional couplings between adjacent bases exert the largest influence on C5 binding. The limited resolution of the structural model of RNase P protein bound to RNA ^[@R9]^ currently precludes structural interpretation of these effects. However, we note that functional coupling between neighboring bases also contributes markedly to the binding of several specific transcription factors to DNA ^[@R21],[@R24],[@R25]^.

Taken together, the examination of the functional binding data with models of increasing complexity reveals defined rules for substrate binding by C5. The data demonstrate that discrimination between different substrates, and thus specificity, is an inherent property of C5. However, this specificity is "hidden" in the cellular RNA targets. This observation raises the question why the specificity in C5 has not led to selection of ptRNA leaders with high affinity sequence signatures, as seen in proteins with canonical specificity ^[@R18]--[@R21]^. Our data suggest a farther reaching utility of specificity. C5 employs its inherent specificity, as reflected in the rules for substrate recognition, to enable binding of diverse substrate variants with similar functional affinity. This enables RNase P to process these diverse substrates at a similar rate, which may be required for cellular tRNA homeostasis ^[@R26]^.

The striking similarities between affinity distributions of C5 and those of highly specific transcription factors also raise questions about the concept of "non-specific" RNA binding proteins. Given that RNA binding requires a protein interface to establish interactions with the RNA, certain RNA sequence or structure variants conceivably fit this interface better than others. Genuine "non-specificity" might thus be difficult to accomplish, even for proteins binding exclusively to the RNA backbone, because sequence differences impact backbone geometry ^[@R27]^. Differences between substrate variants may become smaller for proteins that bind to the backbone of RNA duplexes, which show less structural heterogeneity, but are nevertheless dynamic ^[@R28]^.

Preferences of apparently non-specific proteins for certain binding site variants are thus likely to impact substrate selection, unless compensation for these preferences exist. Compensation may arise from varying concentrations of RNA species, rate determining metabolic steps other than substrate binding, or a combination thereof. Alternatively, a single protein could bind multiple distinct substrate regions while thermodynamically compensating for the preferences at each region, as shown for uniform binding of diverse aminoacyl tRNAs to EF-Tu ^[@R29]^.

While hidden specificity remains to be revealed for other proteins, the findings for C5 indicate that absence of sequence or structure signatures in cellular binding sites does not reflect an inability to discriminate between different RNA binding sites. At the same time, the data highlight the key difference between the hidden specificity of C5 and proteins that are specific in a canonical sense. For proteins with canonical specificity, cellular substrates appear to fall mainly into the high affinity region of the sequence distribution. This region is associated with sequence signatures, even for C5. Biological substrates for C5 bind near the median of the affinity distribution, which does not produce a sequence signature. These findings suggest that specific and "non-specific" binding modes might not fundamentally differ, but represent distinct parts of similar affinity distributions. Our data thus have potentially broad implications for RNA binding by proteins thought to be "non-specific", including many RNases, RNA helicases, or the La-protein.

Methods Summary {#S1}
===============

ptRNAs and ptRNA^Met^ with randomized leader sequences were produced by *in vitro* transcription from PCR-generated templates. RNase P processing reactions were performed with 1 μM ptRNA and 5 nM RNase P holoenzyme (equimolar RNase P RNA and C5). Product and unreacted ptRNA were separated by PAGE. cDNA libraries for *Illumina* sequencing were prepared from unreacted ptRNA at each given timepoint. Primers with degenerate barcodes were used to detect biased PCR amplification of certain sequences. Sequencing was performed on an *Illumina* GA2. Relative rate constants ^r^*k* for individual substrate variants were calculated from changes in the distribution of substrates over time, using a multiple turnover reaction scheme for competitive substrate kinetics, which was extended to several thousand substrates. Computational modeling for the rules of substrate discrimination was performed by ordinary least squares regression of the matrix of values for ln(^r^*k*) for each sequence variant according to four models of increasing complexity. The quality of the different models was judged by the correlation coefficient between a dataset calculated from values obtained from the regression analysis and the set of experimentally obtained values for ln(^r^*k*).

Supplementary Material {#S2}
======================

###### Extended Data Figure 1

Alignment and sequence logos for the C5 binding site in all 87 ptRNA leaders encoded by *E. coli*. Binding of C5 to the consecutive ptRNA positions −3 to −8 is well established, based on a crystal structure ^[@R9]^ and biochemical evidence ^[@R10]^. That is, looping of bases seen for certain RNA and DNA binding proteins, does not occur with C5. Consistent with this notion, we did not detect any sequence motif with the MEME software, when including positions −1 to −10. (**a**) Sequence alignment. Sequences were aligned with CLUSTAL. Colored squares indicate the bases (C: blue, A: green, U: red, G: black), "tRNA \#" the tRNA ID number, "tRNA type" the amino acid, and "Anticodon" the anticodon recognized by the tRNA. (**b**) Sequence logo depicting the probability of any base at a given position, based on the alignment in panel (a). The logo was generated with Weblogo. (**c**) Sequence logo for the information content of the alignment in panel (a). The logo was generated with Weblogo.

###### Extended Data Figure 2

(**a**) Preparation of DNA libraries for *Illumina* sequencing. NN indicates the degenerated barcode, BAR the indexing barcode. For primer sequences see [Supplementary Methods](#SD1){ref-type="supplementary-material"}. (**b**) DNA libraries (PCR products, panel (a)) for samples at the timepoints indicated. Controls: lane 5 - no RNA, lane 6 - no reverse transcriptase. (**c**) Read structure. nt 1,2 -degenerated barcode, nt 3 - 5: sample barcode (index tag), nt 6--29: additional leader sequence, nt 30--35: randomized leader sequence, nt \> 38: tRNA.

###### Extended Data Table 1

Sequencing data. Overall number of reads obtained for the respective timepoints in the independent replicate experiments 1 and 2, and number of reads that passed the quality control.

^(a)^ The fraction of processed ptRNA was determined from PAGE data ([Fig. 1e](#F1){ref-type="fig"}, [Supplementary Methods](#SD1){ref-type="supplementary-material"}).

^(b)^ Read numbers after filtering for potential PCR artifacts for each sequence variant ([Supplementary Methods](#SD1){ref-type="supplementary-material"}).

###### Extended Data Figure 3

Multiple turnover reaction scheme. E: enzyme, S~1\....i~: individual substrate variants, ES~1\...i~: individual enzyme substrate complexes, *K*~1\...i~: individual functional binding constants, V~1\...i~: individual reaction rate constants.

###### Extended Data Figure 4

Effect of the 21 nt extension on ptRNA processing by RNase P for fast, intermediate and slow reacting leader sequences. (**a**) Relative processing rate constants were measured for three sequence variants from different parts of the affinity distribution by PAGE. Reactions for each sequence variant were conducted in the presence of the randomized population (unlabeled) with equal amounts of substrate with (S/21) and without the 21 nt extension (S/nL). The asterisk marks the position of the radiolabel at the 5′ end of the substrate. Reactions were conducted under the conditions described in **Methods**. (**b**) PAGE for the reaction of the reference sequence variant. The timepoint at 5 min is marked for reference. (**c**) Effects of the 21 nt extension on relative processing rate constants of the three indicated sequence variants. The position of each sequence variant in the affinity distribution of all sequence variants ([Fig. 2d](#F2){ref-type="fig"}) is given for reference by the vertical line above the plot. The number indicates the factor (S/nL)/(S/21) by which the 21 nt extension decreases the relative rate constant of the given sequence variant, given as average from three independent experiments. The horizontal line approximates the degree of the relative change. The 21 nt extension decreases the observed ^r^*k* for sequence variant (CTCCTG) by a factor of 2.3. For the genomically encoded leader sequence AAAAAG, the 21 nt extension decreases ^r^*k* for by a factor of 0.95, *i.e.,* the substrate with the extension reacts slightly faster than the substrate without extension. The fast reacting substrate (TTATAT) is also only minimally affected by the extension (0.92). Together, the data show only minor effects of the 21 nt extension on the position of a given sequence variant in the affinity distribution.

###### Extended Data Figure 5

Distribution of ^r^*k* values for processing of ptRNA^Met(-3-8)^ by RNase P without C5 (black line). Data were obtained analogously to those with C5. For comparison, the distribution of ^r^*k* values with C5 is shown (red line).

###### Extended Data Figure 6

Sequence logos are only associated with the high affinity tail of the distribution. (**a**) Plot of sequence variants ranked from weakest to tightest binder to the specific transcription factor Arid3a ([Fig. 2d](#F2){ref-type="fig"}), based on data published by Badis *et al*. ^[@R18]^. To facilitate direct comparison to the 6 nt bindig site of C5, only roughly half of all sequences are shown in the plot, and only 6 positions (2 to 7, as indicated) of the 8 nt binding site are shown. The position in the binding site is marked on the right. The brackets mark 0.1% of sequence variants (33 sequences) that bind tightest, fall into the medium, and bind weakest. Sequence logos show the information content in these sequences. The logos were generated with Weblogo. Sequence signatures of the tightest binding variants are highly enriched in physiological substrates of Arid3a ^[@R18]^. (**b**) Plot of sequence variants ranked from weakest to tightest binder to another specific transcription factor, Hnf4a, based on data published by Badis *et al*. ^[@R18]^. Roughly half of all sequences are shown in the plot, and 6 positions (2 to 7, as indicated) of the 8 nt binding site. Sequence signatures of the tightest binding variants are highly enriched in physiological substrates of Hnf4A ^[@R18]^. (**c**) Plot of sequence variants ranked from slowest to fastest reacting for C5 ([Fig. 2e](#F2){ref-type="fig"}). The brackets mark 1% of sequence variants that react fastest bind tightest, fall into the medium and react slowest. Sequence logos were generated as in panel (a).

###### Extended Data Figure 7

Sequence determinants for substrate recognition by C5. (**a**) Model considering identity, but not position of a given base in the C5 binding site. Ranking of the four bases according to their potential to promote (positive linear coefficient) or decrease (negative linear coefficient) functional C5 binding. For calculation of linear coefficients, see Methods. (**b**) Position Weight Matrix (PWM) model considering both, base identity and position in the binding site, but assuming independent contributions of each position. The plot shows the ranking of the bases according to their potential to promote (positive linear coefficient) or decrease (negative linear coefficient) functional C5 binding, relative to the reference sequence (AAAAAG, [Fig. 1c](#F1){ref-type="fig"}). Bases are colored as in panel (a). For calculation of linear coefficients, see Methods.

###### Extended Data Figure 8

Correlation between observed ^r^*k* and values calculated with the best model obtained by neural network analysis ([Supplementary Methods](#SD1){ref-type="supplementary-material"}).
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![Processing of ptRNA with randomized leader sequences\
(**a**) ptRNA processing reaction by RNase P. (**b**) Structure of the RNase P holoenzyme ^[@R9]^. (**c**) Sequences of non-initiator ptRNA^Met^ leaders (reference: black; randomized: red). The tRNA body is omitted for clarity. The arrow indicates the cleavage site. (**d**) Timecourses of RNase P processing of ptRNA^Met82^ (black), and ptRNA^Met(-3-8N)^ (red), in the presence (filled circles), and in the absence of C5 (open circles). The solid lines are fits to the integrated rate equation for a biphasic first order reaction. (**e**) PAGE of reactions processed for Illumina sequencing. (**f**) Distributions of species for individual timepoints, ranked from fastest to slowest. Distributions are normalized to *t* = 0.](nihms516115f1){#F1}

![Discrimination of C5 between different ptRNA^Met^ leader sequences\
(**a**) Relative rate constants (^r^*k*) for processing of all ptRNA leader sequence variants, ranked from slow to fast. Relative rate constants are averaged from four values (two timepoints of two experiments) and shown for only sequences where data from all four measurements passed quality control criteria ([Extended Data Tab. 1](#SD4){ref-type="supplementary-material"}). The line at ^r^*k* = 1 marks the reference sequence. (**b**) Correlation of relative rate constants from two independent biological replicates (red line: linear fit through the data, R^2^: correlation coefficient). (**c**) Correlation between relative rate constants obtained by PAGE and by the HiTS-Kin approach for selected sequence variants. Error bars represent the standard deviation of multiple individual experiments. (**d**) Distribution of relative rate constants for processing of ptRNA^Met(-3-8N)^ sequence variants by C5 (black) and apparent affinities for DNA binding by the transcription factor Arid3a, indicated as Z-scores based on published microarray data ^[@R18]^. The Z-score is not identical to ^r^*k* values, but accurately reflects affinity-based ranking of all sequences ^[@R18]^ (triangles: ^r^*k* values for genomic leader sequences of ptRNA^Met^). (**e**) Plot of all sequence variants ranked from slowest to fastest processed. The bracket marks of 0.3% of sequence variants with the largest relative rate constants. (**f**) Sequence logo for this fraction.](nihms516115f2){#F2}

![Rules for sequence discrimination by C5\
(**a**) Correlation between observed ^r^*k* and values calculated with the best fit of the data to models of increasing complexity. Logarithmic ^r^*k* values are used because of their correspondence to differences in binding energies ^[@R30]^. R^2^ expresses the correlation of each model with measured processing rate constants. (**b**) Functional coupling between two base positions. Yellow squares show promotion of processing (high linear coefficients), black squares indicate small or no effects, blue squares mark inhibition of processing.](nihms516115f3){#F3}
